WHITEHAWK THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Deferred Tax Assets, Operating Loss Carryforwards of $26.50 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.50M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $49.18M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $43.69M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $38.55M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $26.50M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $49.18M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $43.69M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $38.55M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $34.23M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $7.26M 10-K · filed 2022-03-17 | $26.18M 10-K · filed 2021-03-11 |
| 2019-12-31 | $24.97M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $19.95M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $18.82M 10-K · filed 2019-03-07 | |
| 2016-12-31 | $23.15M 10-K · filed 2018-03-15 | $14.40K 10-K · filed 2017-03-07 |
| 2015-12-31 | $11.00K 10-K · filed 2017-03-07 | |
| 2014-12-31 | $8.20K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $5.80K 10-K · filed 2015-02-27 | |
| 2012-12-31 | $3.80K 10-K · filed 2014-03-31 | |
| 2011-12-31 | $2.20K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |